Transjugular Intrahepatic Portosystemic Shunt

被引:79
作者
Patidar, Kavish R. [1 ]
Sydnor, Malcolm [2 ]
Sanyal, Arun J. [3 ]
机构
[1] Virginia Commonwealth Univ Hosp, Dept Internal Med, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ Hosp, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Richmond, VA 23298 USA
关键词
Transjugular intrahepatic portosystemic shunt; Esophageal varices; Ascites; Hepatic hydrothorax; Hepatorenal syndrome; Hepatopulmonary syndrome; Venoocclusive disease; Budd-Chiari syndrome; BUDD-CHIARI-SYNDROME; REFRACTORY HEPATIC HYDROTHORAX; SEVERE VENOOCCLUSIVE DISEASE; PARACENTESIS PLUS ALBUMIN; ENDOSCOPIC VARICEAL LIGATION; BLEEDING GASTRIC VARICES; PREDICT POOR SURVIVAL; STENT-SHUNT; LONG-TERM; PORTAL-HYPERTENSION;
D O I
10.1016/j.cld.2014.07.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for the complications of portal hypertension. The largest body of evidence for its use has been supported for recurrent or refractory variceal bleeding and refractory ascites. Its use has also been advocated for acute variceal bleed, hepatic hydrothorax, and hepatorenal syndrome. With the replacement of bare metal stents with polytetrafluoroethylene-covered stents, shunt patency has improved dramatically, thus, improving outcomes. Therefore, reassessment of its utility, management of its complications, and understanding of various TIPS techniques is important.
引用
收藏
页码:853 / +
页数:25
相关论文
共 119 条
[1]   HEPATIC HYDROTHORAX - CAUSE AND MANAGEMENT [J].
ALBERTS, WM ;
SALEM, AJ ;
SOLOMON, DA ;
BOYCE, G .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (12) :2383-2388
[2]   A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites [J].
Albillos, A ;
Bañares, R ;
González, M ;
Catalina, MV ;
Molinero, LM .
JOURNAL OF HEPATOLOGY, 2005, 43 (06) :990-996
[3]   Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents [J].
Angermayr, B ;
Cejna, M ;
Koenig, F ;
Karnel, F ;
Hackl, F ;
Gangl, A ;
Peck-Radosavljevic, M .
HEPATOLOGY, 2003, 38 (04) :1043-1050
[4]   Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation [J].
Azoulay, D ;
Castaing, D ;
Lemoine, A ;
Hargreaves, GM ;
Bismuth, H .
BONE MARROW TRANSPLANTATION, 2000, 25 (09) :987-992
[5]   Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices [J].
Barange, K ;
Péron, JM ;
Imani, K ;
Otal, P ;
Payen, JL ;
Rousseau, H ;
Pascal, JP ;
Joffre, F ;
Vinel, JP .
HEPATOLOGY, 1999, 30 (05) :1139-1143
[6]   Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents [J].
Barrio, J ;
Ripoll, C ;
Bañares, R ;
Echenagusia, A ;
Catalina, MV ;
Camúñez, F ;
Simó, G ;
Santos, L .
EUROPEAN JOURNAL OF RADIOLOGY, 2005, 55 (01) :120-124
[7]   TIPS: Short- and long-term results: A survey of 1750 patients [J].
Barton, RE ;
Rosch, J ;
Saxon, RR ;
Lakin, PC ;
Petersen, BD ;
Keller, FS .
SEMINARS IN INTERVENTIONAL RADIOLOGY, 1995, 12 (04) :364-367
[8]   Using Transjugular Intrahepatic Portosystemic Shunts for Complications of Cirrhosis [J].
Bhogal, Harjit K. ;
Sanyal, Arun J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (11) :936-946
[9]   Prevention of variceal rebleeding [J].
Bosch, J ;
García-Pagán, JC .
LANCET, 2003, 361 (9361) :952-954
[10]   Transjugular intrahepatic portosystemic shunt: Current status [J].
Boyer, TD .
GASTROENTEROLOGY, 2003, 124 (06) :1700-1710